Impact of treatment of diabetic macular edema on visual impairment in people with diabetes mellitus in India
Open Access
- 1 March 2021
- journal article
- research article
- Published by Medknow in Indian Journal Of Ophthalmology
- Vol. 69 (3) , 671-676
Abstract
Purpose: The aim of this study was to report visual and anatomical outcomes following treatment for diabetic macular edema (DME) in clinical practice in India. Methods: Retrospective chart review of patients with DME who were initiated on treatment and followed up for at least 1 year at 9 tertiary eye care centers during 2016–2017 was performed. Data on demographics, systemic illnesses, visual acuity and anatomical characteristics of DME, treatment history were collated and analyzed for change in visual acuity level and central macular thickness at 1 year. Results: A total 1853 patients were diagnosed with treatable DME during study period, 1315 patients were treated and 556 patients (1019 eyes) followed up at one year. Although patients achieved significantly better anatomical outcome (central macular thickness of P < 0.001), visual impairment due to DME did not differ from baseline (mild visual impairment in 53.2% at baseline compared to 56% at 1 year, P = 0.7). Cystoid type of DME was the most common phenotype (432/1019, 42.4%) followed by spongy type (325, 31.9%) and cystoid plus spongy type (138, 13.5%). Bevacizumab monotherapy was the most common (388/1019, 38.1%) treatment followed by combination therapy (359, 35.2%). Mean number of anti-VEGF injections received per eye in a year was 2.1 (SD ± 0.9). Conclusion: Only about a third of treated DME patients complete one year follow up in India. Most patients receive suboptimal number of treatments. Treated DME cases largely show better anatomical outcome but not a better functional outcome.Keywords
This publication has 23 references indexed in Scilit:
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Social inequalities in blindness and visual impairment: A review of social determinantsIndian Journal Of Ophthalmology, 2012
- Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and AdolescentsDiabetes, 2010
- Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulationBritish Journal of Ophthalmology, 2009
- Prevalence of Diabetic Retinopathy in IndiaOphthalmology, 2009
- Rapid Assessment of Avoidable Blindness in IndiaPLOS ONE, 2008
- Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian populationIndian Journal Of Ophthalmology, 2007
- Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, IInvestigative Ophthalmology & Visual Science, 2005
- Treatment Techniques and Clinical Guidelines for Photocoagulation of Diabetic Macular EdemaOphthalmology, 1987
- PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA: EARLY TREATMENT DIABETIC RETINOPATHY STUDY REPORT NO. 4International Ophthalmology Clinics, 1987